Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experiment.

ABSTRACT:

Background

As the therapeutic landscape for inflammatory bowel disease (IBD) continues to expand, a need exists to understand how patients perceive and value different attributes associated with their disease as well as with current and emerging treatments. These insights can inform the development and regulation of effective interventions for IBD, benefiting various stakeholders including healthcare professionals, drug developers, regulators, Health Technology Assessment bodies, payers, and ultimately patients suffering from IBD. In response to this, the present patient preference study was developed with the aim to (1) determine the relative preference weights for IBD treatment and disease related attributes, and (2) explain how preferences may differ across patients with differe

SUBMITTER: Schoefs E 

PROVIDER: S-EPMC11349669 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature